Evidence check: WeightLoss | SLIM DNA-Test in the context of Blutzucker

The MyBody-X SLIM DNA Test in the context of blood sugar and weight loss has weak scientific support. The SNPs tested typically have small effect sizes on metabolism, and the evidence is mostly from association studies or mechanistic data, not from randomized controlled trials. Blood sugar regulation is heavily influenced by diet, exercise, sleep, and stress – a DNA test alone cannot provide personalized blood sugar management. The Firmicutes/Bacteroidetes ratio, often included in such tests, is not clinically validated. Variants like VDR or NQO1 have no proven relevance for weight loss or glycemic control. MyBody-X itself labels some of these tests as marketing. For improving blood sugar, established methods like continuous glucose monitoring, tailored nutrition, and physical activity are far more effective. Caveat: These tests may serve as a motivational tool for lifestyle changes, but they are not medical diagnostics.